Mechanical Circulatory Support

Medtronic HVAD™ System

AATS 2021   

Discover Why HVAD

THE FIRST VAD APPROVED  FOR THE LESS-INVASIVE THORACOTOMY APPROACH

The HVAD™ Pump is the world’s smallest commercially available, full-support, centrifugal VAD, enabling unmatched procedural versatility. It is also the only full-support, durable VAD with clinical evidence to prove its safety and effectiveness when used in a less-invasive thoracotomy approach.

Download the Brochure
Thoracotomy

 

WATCH A Thoracotomy Procedure

Watch as Dr. David Kaczorowski demonstrates HAVDTM Pump Implantation via the less-invasive thoracotomy approach. This collection of six videos provides a step-by-step overview of the procedure — from Patient History Selection through Closure Techniques.

Watch the Video Series
Dr Kaczorowski

Dr. David J. Kaczorowski

Surgical Director, Cardiac Transplantation & Mechanical Circulatory Support

The Economic Value of the Less-invasive
Thoracotomy Approach

A recent analysis of the LATERAL Trial database and the Medicare database found that HVAD implantation via the less-invasive thoracotomy approach resulted in:

  • A 30% relative reduction in length of stay compared to sternotomy approach1,2 
  • An absolute average reduction in cost of more than $50,000 compared to sternotomy approach1,2

Read the Analysis
Illustrated graph displaying the average cost of VAD Implant Hospitalization.

Discover Whats New

Discover the latest advancements in VAD therapy, including the Carbothane driveline, Autologs™ 1.3, and Quick Connect. This is HVAD, enhanced.

Discover HVAD Enhanced
HVAD product image on gray background
CONTACT

Would you like to learn more about Medtronic products?

Contact us
1

Mokadam NA, McGee E, Wieselthaler G, et al. Cost of Thoracotomy Approach: An Analysis of the LATERAL Trial. Ann Thorac Surg. Published online March 26, 2020.

2

McGee E Jr, Danter M, Strueber M, et al. Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial. J Heart Lung Transplant. April 2019;38(4):344-351.

Medtronic HVAD System Brief Statement

*

Indications The Medtronic HVAD System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a Bridge to Cardiac Transplantation (BTT), myocardial recovery, or as Destination Therapy (DT) in patients for whom subsequent transplantation is not planned.

Contraindications The HVAD System is contraindicated in patients who cannot tolerate anticoagulation therapy.

Warnings and Precautions Proper usage and maintenance of the HVAD System is critical for the functioning of the device. Serious and life-threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta -use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post CPR.

Potential Complications Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity.  There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and device-related thromboembolic events, bleeding, right ventricular failure, infection, hemolysis and sepsis.  Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions and potential adverse events prior to using this device.

Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.